$NUWE I am way down on this Co, and the position became unfortunately small. The debate is if I hold or not? Here are some of the catalysts that can be positive: -Rebound of elective admissions for heart failure and pediatric cases in Q4 as covid has receded. -Hospitals opened back up to sales force interactions. -Approval of the peripheral catheter for outpatient procedures. -January 1st, outpatient procedures are approved and can be billed / reimbursed to physicians as the new CPT code goes into effect. (this can be a huge solution to their dismal outpatient cases performed so far). -Yet again, I highly suggest that everyone on here to send management an email at to complain about the poor performance and demand better decisions to turn around the stock.
1 Like